Management of acute cardiovascular events in patients with COVID-19

Chia-Te Liao1,2,3, Wei-Ting Chang1,4,5, Wen-Liang Yu6,7

  • 1Department of Cardiology, Chi Mei Medical Center, 71004, Tainan, Taiwan.

Insights

This review offers guidance for managing critical cardiovascular diseases during the COVID-19 pandemic. It addresses ST-elevation myocardial infarction (STEMI) and other emergencies, prioritizing patient and clinician safety.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Public Health

Background:

  • Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, presents significant morbidity and mortality.
  • COVID-19 can lead to cardiovascular damage, worsening patient prognosis.
  • Managing critical cardiovascular events during the pandemic requires balancing infectious disease control with optimal patient care.

Purpose of the Study:

  • To provide comprehensive guidance for managing critical cardiovascular diseases during the COVID-19 epidemic.
  • To address specific conditions including ST-segment elevation myocardial infarction (STEMI), non-STEMI acute coronary syndrome, cardiogenic shock, acute heart failure, cardiopulmonary resuscitation, and advanced care planning.
  • To ensure prompt and optimal treatments while considering clinician safety and healthcare capacity.

Main Methods:

  • This is a review article.
  • It synthesizes current knowledge and expert recommendations.
  • Focuses on critical cardiovascular conditions and their management during the COVID-19 pandemic.

Main Results:

  • Cardiovascular injury is a significant complication of COVID-19, impacting prognosis.
  • Effective management strategies must integrate infectious control measures.
  • The review outlines approaches for STEMI, non-STEMI ACS, cardiogenic shock, acute heart failure, CPR, and care planning.

Conclusions:

  • Integrated management protocols are crucial for critical cardiovascular diseases amidst the COVID-19 pandemic.
  • Guidance addresses the unique challenges posed by SARS-CoV-2 infection.
  • Optimizing care requires a multi-faceted approach considering patient outcomes and healthcare system constraints.

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
97
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
131
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
80
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
93
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
255
Pericarditis IV: Nursing Management01:25

Pericarditis IV: Nursing Management

Pericarditis, an inflammation of the pericardium, necessitates diligent nursing management to ensure effective patient care and recovery. The initial step in managing pericarditis is a comprehensive patient medical assessment.The patient reports chest pain aggravated by breathing, coughing, and swallowing, which worsens when lying supine. The pain often improves when sitting up and leaning forward. Additional symptoms may include fever, malaise, and, in severe cases, signs of heart failure.
168